Sun Pharma and Rohto Recall Eye Drops Over Contamination and Sterility Concerns
Sun Pharma has recalled multiple eye drop brands in India, including Lotepred and Brinolar, due to contamination concerns, requesting distributors to cease sales and return existing stocks. The company emphasized patient safety and regulatory compliance while working to restore product availability. Separately, the US FDA issued a Class II recall of nearly 12 million Rohto Cooling Eye Drops over sterility concerns, advising consumers to stop use. Experts highlight the importance of sterility in eye drops to prevent health risks, especially for patients with chronic eye conditions.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 55/100.
Outlets measured: economictimes, thefinancialexpress, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 1 Aug, 02:02 pm. Other outlets followed.